Last reviewed · How we verify
intravenous immune globulin — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
intravenous immune globulin (intravenous immune globulin) — National Taiwan University Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| intravenous immune globulin TARGET | intravenous immune globulin | National Taiwan University Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- intravenous immune globulin CI watch — RSS
- intravenous immune globulin CI watch — Atom
- intravenous immune globulin CI watch — JSON
- intravenous immune globulin alone — RSS
Cite this brief
Drug Landscape (2026). intravenous immune globulin — Competitive Intelligence Brief. https://druglandscape.com/ci/intravenous-immune-globulin. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab